Goldman Sachs initiates CRCT at Sell with $4.50 target
Goldman Sachs assumed coverage of CRCT with a Sell rating and a $4.50 price target, with no catalyst supplied in the alert.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.